12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

  • ContraFect CFRX stock rose 17.5% to $0.47 during Friday's after-market session. The market value of their outstanding shares is at $2.5 million.
  • Exagen XGN shares rose 15.63% to $2.44. The market value of their outstanding shares is at $41.1 million.
  • Pasithea Therapeutics KTTA stock rose 15.0% to $0.46. The market value of their outstanding shares is at $9.5 million.
  • Talaris Therapeutics TALS stock moved upwards by 10.25% to $2.98. The market value of their outstanding shares is at $130.8 million.
  • Renalytix RNLX stock moved upwards by 8.94% to $1.34. This security traded at a volume of 67.0K shares come close, making up 56.8% of its average volume over the last 100 days. The company's market cap stands at $63.6 million.
  • GRI Bio GRI stock moved upwards by 8.85% to $1.72. The market value of their outstanding shares is at $5.0 million.

Losers

  • Addex Therapeutics ADXN shares declined by 10.8% to $0.38 during Friday's after-market session. At the close, Addex Therapeutics's trading volume reached 609.2K shares. This is 1094.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.0 million.
  • Dyadic International DYAI shares decreased by 9.81% to $1.84. The company's market cap stands at $53.0 million.
  • Sunshine Biopharma SBFM shares decreased by 9.47% to $0.33. The market value of their outstanding shares is at $8.4 million.
  • Senti Biosciences SNTI stock fell 6.6% to $0.34. The company's market cap stands at $15.1 million.
  • First Wave BioPharma FWBI stock decreased by 5.55% to $0.31. The company's market cap stands at $4.1 million.
  • Salarius Pharmaceuticals SLRX shares fell 5.17% to $0.62. The company's market cap stands at $2.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!